Rising prices in sight? According to experts, Alibaba and Bayer offer high potential!

Rising prices in sight? According to experts, Alibaba and Bayer offer high potential!

According to a report by www.aktienwelt360.de,

The shares of Alibaba and Bayer are currently in the focus of analysts because they have significant price potential. The shares of both companies are classified as promising and promising, and various growth and valuation factors point to a positive development.

The shares of Alibaba, also known as the “Chinese Amazon”, recently recorded impressive international sales growth of 53% in the third quarter of 2023. In addition, a low price-earnings ratio (P/E) of 9.4 is recorded, and concrete spin-off fantasies could make the stock more interesting in the future. Analysts see upside potential of 72.8% and over 80% of analysts recommend buying, although there are geopolitical and domestic risks.

Bayer stock is considered a value pick with a low forward P/E ratio of 6.9, although the company faces various risks, particularly related to the Monsanto acquisition. Nevertheless, a price potential of over 50% is seen, and the company was able to achieve a positive operating result despite challenges.

Although analysts see attractive price potential for both stocks, they also urge caution given the existing risks. It is important to carefully weigh opportunities and risks, as uncertainties account for part of the current price weakness.

Alibaba's low valuation and the potential for international growth as well as Bayer's intrinsic strength are seen as positive factors that strengthen the share price potential. However, the influence of factors such as geopolitical risks and business challenges should also be considered to make informed investment decisions.